Telix Pharmaceuticals (Australia) Market Value
| TLX Stock | 24.74 0.96 4.04% |
| Symbol | Telix |
Telix Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Telix Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Telix Pharmaceuticals.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Telix Pharmaceuticals on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Telix Pharmaceuticals or generate 0.0% return on investment in Telix Pharmaceuticals over 30 days. Telix Pharmaceuticals is related to or competes with Aurelia Metals, Ainsworth Game, 29Metals, and Ras Technology. Telix Pharmaceuticals is entity of Australia More
Telix Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Telix Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Telix Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.67 | |||
| Information Ratio | 0.1293 | |||
| Maximum Drawdown | 12.13 | |||
| Value At Risk | (3.49) | |||
| Potential Upside | 4.16 |
Telix Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Telix Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Telix Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Telix Pharmaceuticals historical prices to predict the future Telix Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.1476 | |||
| Jensen Alpha | 0.3818 | |||
| Total Risk Alpha | 0.0329 | |||
| Sortino Ratio | 0.1221 | |||
| Treynor Ratio | 0.8083 |
Telix Pharmaceuticals Backtested Returns
Telix Pharmaceuticals appears to be very steady, given 3 months investment horizon. Telix Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.21, which indicates the firm had a 0.21% return per unit of risk over the last 3 months. By inspecting Telix Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please review Telix Pharmaceuticals' Semi Deviation of 2.18, coefficient of variation of 543.63, and Risk Adjusted Performance of 0.1476 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Telix Pharmaceuticals holds a performance score of 16. The entity has a beta of 0.56, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Telix Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Telix Pharmaceuticals is expected to be smaller as well. Please check Telix Pharmaceuticals' value at risk, expected short fall, and the relationship between the treynor ratio and downside variance , to make a quick decision on whether Telix Pharmaceuticals' existing price patterns will revert.
Auto-correlation | 0.31 |
Below average predictability
Telix Pharmaceuticals has below average predictability. Overlapping area represents the amount of predictability between Telix Pharmaceuticals time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Telix Pharmaceuticals price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current Telix Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | 0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 0.59 |
Telix Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Telix Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Telix Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Telix Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Telix Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Telix Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Telix Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Telix Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Telix Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Telix Pharmaceuticals Lagged Returns
When evaluating Telix Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Telix Pharmaceuticals stock have on its future price. Telix Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Telix Pharmaceuticals autocorrelation shows the relationship between Telix Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Telix Pharmaceuticals.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.